Home47N0 • FRA
add
Citius Pharmaceuticals Inc
Previous close
€3.29
Year range
€3.29 - €3.29
Market cap
26.02M USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.63M | 22.63% |
Net income | -10.57M | -24.70% |
Net profit margin | — | — |
Earnings per share | -1.50 | 0.00% |
EBITDA | -10.63M | -22.63% |
Effective tax rate | -1.38% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.91M | -46.18% |
Total assets | 97.09M | -12.06% |
Total liabilities | 10.81M | -10.73% |
Total equity | 86.28M | — |
Shares outstanding | 7.23M | — |
Price to book | 0.28 | — |
Return on assets | -28.31% | — |
Return on capital | -31.85% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -10.57M | -24.70% |
Cash from operations | -8.37M | 12.68% |
Cash from investing | — | — |
Cash from financing | 13.72M | -0.58% |
Net change in cash | 5.35M | 26.93% |
Free cash flow | -4.64M | 29.89% |
About
Founded
2007
Headquarters
Website
Employees
22
